{"GHMDC classification":["Treatment"],"GHMDC health topic":["Child mortality"],"GHMDC manufacturer coordinates":["35.672963888889, -79.039291666667"],"GHMDC manufacturer location":["North Carolina, United States"],"Page SDG":["SDG09 Industry innovation and infrastructure","SDG03 Good health and well-being"],"Page URL":["https://www.appropedia.org/Global_Health_Medical_Device_Compendium/BiliSol_Phototherapy_System"],"Page affiliations":["Appropedia Foundation","University of Michigan"],"Page authors":["User:Lonny","User:Chriswaterguy","User:Emilio","Kathleen Sienko","Amir Sabet Sarvestani"],"Page description":["Neonatal jaundice occurs when the blood has excessive levels of bilirubin due to the liver not effectively breaking it down, causing the skin and eyes to turn yellow. Preterm babies are more likely to have this condition since their livers are not fully developed. Jaundice affects ⅔ of newborns around the world and roughly 1/10 of these cases are so severe that it could lead to lifelong disability or death. In the developing world where there is a higher percentage of preterm babies, jaundice kills more than 100,000 infants each year and 6 million babies are unable to get effective treatment for jaundice."],"Page image":["File:BiliSol Phototherapy System.JPG"],"Page language":["en"],"Page license":["CC-BY-SA-3.0"],"Page parent":["Global Health Medical Device Compendium"],"Page root":["Global Health Medical Device Compendium"],"Page title":["Global Health Medical Device Compendium/BiliSol Phototherapy System"],"Page views":[94],"Page year":["Thursday, 01-Jan-15 00:00:00 UTC"],"Modification date":["Thursday, 10-Sep-26 14:06:15 UTC"]}